Not applicableStudy completedNCT02051010What this trial is testingABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?Who this might be right forMetastatic Breast Cancer Cancer Trials Ireland 500
Testing effectiveness (Phase 2)Looking for participantsNCT07222215What this trial is testingPhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)Who this might be right forEstrogen-receptor-positive Breast CancerMetastatic Breast CancerBreast Cancer+6 more Kristina A. Fanucci 297
Testing effectiveness (Phase 2)Study completedNCT00033384What this trial is testingCI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more University of Alabama at Birmingham
Early research (Phase 1)Ended earlyNCT00354900What this trial is testingPhase I Study of Aprotinin in Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Dartmouth-Hitchcock Medical Center 18
Early research (Phase 1)Study completedNCT00764036What this trial is testingStudy of Artesunate in Metastatic Breast CancerWho this might be right forMetastatic Breast CancerLocally Advanced Breast Cancer Heidelberg University 23
Early research (Phase 1)Study completedNCT00291577What this trial is testingStudy Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast CancerWho this might be right forBreast Neoplasms Pfizer 22
Not applicableLooking for participantsNCT06507930What this trial is testingThe COMPASSION StudyWho this might be right forBreast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more Dana-Farber Cancer Institute 200
Testing effectiveness (Phase 2)Study completedNCT00791037What this trial is testingVaccine Therapy in Treating Patients With Stage IV Breast CancerWho this might be right forHER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more University of Washington 23
Not applicableStudy completedNCT03339765What this trial is testingSelf-Advocacy Serious Game in Advanced CancerWho this might be right forOvarian Cancer Stage IIIOvarian Cancer Stage IVBreast Cancer Stage IV+10 more University of Pittsburgh 78
Early research (Phase 1)Ended earlyNCT04042051What this trial is testingCopanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerWho this might be right forHER2-positive Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer+1 more Cancer Trials Ireland 2
Post-approval studies (Phase 4)Not Yet RecruitingNCT05860907What this trial is testingClinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisWho this might be right forBreast Cancer Stage IV Fudan University 384
Large-scale testing (Phase 3)Looking for participantsNCT06383767What this trial is testingA Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast CancerWho this might be right forMetastatic Breast Cancer Qilu Pharmaceutical Co., Ltd. 378
Large-scale testing (Phase 3)Active Not RecruitingNCT05257395What this trial is testingXZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Xuanzhu Biopharmaceutical Co., Ltd. 397
Not applicableStudy completedNCT00756132What this trial is testingUsing Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast CaWho this might be right forLocally Advanced Breast CancerBreast Cancer University Health Network, Toronto 120
Testing effectiveness (Phase 2)Study completedNCT02657889What this trial is testingNiraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerWho this might be right forNeoplasmsTriple Negative Breast CancerOvarian Cancer+6 more Tesaro, Inc. 122
Not applicableStudy completedNCT04394247What this trial is testingPatient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination TherapyWho this might be right forBreast Cancer Pfizer 242
Testing effectiveness (Phase 2)Study completedNCT02630693What this trial is testingTwo Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast CancerWho this might be right forBreast Cancer Canadian Cancer Trials Group 180
Early research (Phase 1)Ended earlyNCT04274933What this trial is testingEvaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor TherapyWho this might be right forBreast CancerCancer AbbVie 4
Testing effectiveness (Phase 2)UnknownNCT00066547What this trial is testingMonoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination ChemotherapyWho this might be right forBreast Cancer Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT03084939What this trial is testingEfficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 351